Navigation Links
Europe's most common genetic disease is a liver disorder
Date:2/6/2008

Much less widely known than the dangerous consequences of iron deficiencies is the fact that too much iron can also cause problems. The exact origin of the genetic iron overload disorder hereditary hemochromatosis (HH) has remained elusive. In a joint effort, researchers from the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have now discovered that HH is a liver disease. They report in the current issue of Cell Metabolism that the disorder develops when a crucial gene is lacking in liver cells.

Iron is essential for our body, because it is a central component of red blood cells. Too little iron can lead to dangerous anemias, but also too much iron can be detrimental as it promotes the formation of toxic radicals that lead to tissue damage. Hereditary hemochromatosis is an iron overload disorder that, affecting about one in 300 people, is probably the most common genetic disorder in Europe. Scientists have identified a gene, called HFE, that when mutated causes hemochromatosis in mice and humans. But as yet it is unknown in which tissue or organ the gene is acting to prevent iron overload.

A group of researchers around Matthias Hentze at EMBL and Martina Muckenthaler and Wolfgang Stremmel at the University of Heidelberg have now found that mice that are genetically engineered to lack HFE only in liver cells show all central features of the disease.

For a long time scientists thought of HH as a disease of the intestine, because this is where iron uptake actually takes place, says Matthias Hentze, Associate Director of EMBL. Our research now reveals the crucial point is actually the liver and explains why HH patients suffer from increased iron absorption.

HFE encodes a protein that is likely involved in transmitting signals about the current iron contents of the body to liver cells. In response to these signals, the liver cells make a special iron hormone, hepcidin that is released into the blood stream and reduces iron uptake in the intestine.

HFE influences hepcidin expression through a series of intermediate molecules, but when the HFE gene is mutated the result is that less hepcidin is produced. This in turn means iron uptake in the intestine cannot be limited as effectively and an overload develops, says Martina Muckenthaler, professor at the University of Heidelberg.

The research is a landmark for the joint Molecular Medicine Partnership Unit of EMBL and the University of Heidelberg. The Unit is dedicated to elucidating the molecular mechanisms of a range of different diseases, among which disorders of iron metabolism constitute a central focus.


'/>"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
Source:Eurekalert

Related biology news :

1. Blue-eyed humans have a single, common ancestor
2. Disrupting common parasites ability to talk to each other reduces infection
3. U of M research finds disordered eating less common among teen girls who regularly eat family meals
4. Bacterial infections in premature babies more common than previously realized
5. Tiny dust particles from Asian deserts common over western United States
6. Cell response to stress signals predicts tumors in women with common pre-breast cancer
7. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
8. UCI researchers restore memory process in most common form of mental disability
9. Thriving hybrid salamanders contradict common wisdom
10. Genes and environment grant funds close look at nature-nurture overlap in common diseases
11. The importance of gene regulation for common human disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
Breaking Biology News(10 mins):
(Date:7/26/2017)... Coral Springs, FL (PRWEB) , ... July 26, ... ... today announced that the stock market news outlet had initiated coverage on Aytu ... an established and producing commercialization strategy. , According to Soulstring, Aytu Bioscience is ...
(Date:7/26/2017)... /PRNewswire/ - Caprion Biosciences Inc., a world leading specialty CRO announced ... predictive of early stage (latent) Mycobacterium tuberculosis (Mtb) infection using ... (MRM-MS) platform. ... Caprion Biosciences Inc. (CNW Group/Caprion Biosciences) ... The new data, recently published in ...
(Date:7/26/2017)... ... July 25, 2017 , ... Provia ... are necessary in the preparation and development of human cells and tissues for ... the US Food and Drug Administration’s (FDA) Current Good Manufacturing Practices (cGMP) guidelines ...
(Date:7/26/2017)... , July 26, 2017  Nurse practitioners play a ... the findings of a Merck Manuals survey released ... medical conference, revealed that most (88 percent) believe they spend ... treatments and prescriptions. ... Merck Manuals survey of 210 nurse ...
Breaking Biology Technology: